DeMeester T R, Johansson K E, Franze I, Eypasch E, Lu C T, McGill J E, Zaninotto G
Creighton University School of Medicine, Department of Surgery, Omaha, NE 68131.
Ann Surg. 1988 Oct;208(4):460-74. doi: 10.1097/00000658-198810000-00008.
Over a 17-year period, 92 patients with esophageal disease underwent colon interposition or bypass, with each operation performed by the same surgeon. The indication was cure of cancer in 20 patients, relief of dysphagia in 55 (cancer in 17 patients and benign in 38), loss of gastrointestinal (G.I.) continuity in ten, and tracheoesophageal fistula in seven patients (malignant in five, benign in 2). The thirty-day operative mortality rate was 5%, and the hospital mortality rate was 9%. Graft necrosis occurred in seven of 92 patients, four of whom later underwent a successful second reconstruction. Thirteen patients required subsequent revisional surgery. In 85 patients, the left colon based on the inferior mesenteric artery was used, and in seven, the right colon was used. Technical insights were gained to help preserve the blood supply to the graft and improve its function in transporting food. Thirty-four patients were available for interview 2-17 years after operation (median of 5 years) 28 of whom had benign disease, and six of whom had malignant disease); 82% of the patients felt they were cured of their preoperative symptoms, 18% improved, and none worsened. Eighty-eight per cent of the patients were able to receive an unrestricted diet. All patients except one were satisfied with the results of surgery, and, asked what they would do if they had to make the choice again, all responded that they would have the operation. Twenty-six of the interviewed patients had their eating ability evaluated with a test meal and the transit time of a liquid and solid barium bolus measured. Compared to controls, patients with colon interpositions consumed a smaller capacity meal over a longer period of time and were not dependent on liquids to flush the food through the colon graft. A colon interposition provides good quality of deglutition, is very durable, and is the organ of choice for patients who require an esophageal substitute and are potential candidates for long survival.
在17年期间,92例食管疾病患者接受了结肠间置术或结肠旁路术,每例手术均由同一位外科医生进行。手术指征为:20例患者用于癌症根治,55例用于缓解吞咽困难(其中17例为癌症,38例为良性疾病),10例用于恢复胃肠道连续性,7例用于治疗气管食管瘘(5例为恶性,2例为良性)。30天手术死亡率为5%,医院死亡率为9%。92例患者中有7例发生移植物坏死,其中4例后来成功进行了二次重建。13例患者需要后续的修复手术。85例患者使用了以肠系膜下动脉为蒂的左半结肠,7例患者使用了右半结肠。获得了一些技术见解,有助于保留移植物的血供并改善其运输食物的功能。34例患者在术后2至17年(中位时间为5年)接受了访谈(其中28例为良性疾病,6例为恶性疾病);82%的患者认为术前症状已治愈,18%有所改善,无患者症状恶化。88%的患者能够接受不受限制的饮食。除1例患者外,所有患者对手术结果均满意,当被问及如果再次面临选择会怎么做时,所有患者均表示会选择手术。26例接受访谈的患者通过试餐评估了进食能力,并测量了液体和固体钡剂团块的通过时间。与对照组相比,结肠间置术患者进食量较小,但进食时间较长,且不依赖液体来将食物冲过结肠移植物。结肠间置术可提供良好的吞咽质量,非常耐用,是需要食管替代物且有望长期存活的患者的首选器官。